Connection

Aldo Maggioni to Sulfonylurea Compounds

Back to Details
This is a "connection" page, showing publications Aldo Maggioni has written about Sulfonylurea Compounds.
Aldo Maggioni
Connection Strength
1.055
Sulfonylurea Compounds
  1. Risk of heart failure in diabetic patients receiving sulfonylureas. Eur J Heart Fail. 2018 09; 20(9):1371-1372.
    View in: PubMed
    Score: 0.700
  2. Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care. J Clin Endocrinol Metab. 2019 08 01; 104(8):3296-3302.
    View in: PubMed
    Score: 0.189
  3. Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. Lancet Diabetes Endocrinol. 2017 11; 5(11):887-897.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.